antimalarial

On Tuesday, April 21, preliminary results from the largest study to date about the benefits and detriments of using the antimalarial and immunomodulatory drug hydroxychloroquine with or without the antibiotic azithromycin was published online before review by other scientists. Paid for by the National Institutes of Health and the University of Virginia, the results submitted […]